Antimicrobial peptides and methods of use

US11643438B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11643438-B2
Application numberUS-201917260148-A
CountryUS
Kind codeB2
Filing dateJul 19, 2019
Priority dateJul 20, 2018
Publication dateMay 9, 2023
Grant dateMay 9, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Cyclic depsipeptide-class molecules, referred to herein as persephacins (including analogs thereof), having similarities to aureobasidin A, are described. The persephacins have antimicrobial activity, such as antifungal activity against a diverse range of clinically-relevant fungal pathogens, antiprotozoan parasite activity, and antibacterial activity, and can be used for example in treatments of difficult-to-treat ocular fungal infections at lower concentrations than natamycin. The active compounds may be combined with a secondary compound in a composition.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of treating a fungal infection in a subject in need of such treatment, wherein the method comprises: administering to the subject a compound comprising Formula II or a stereoisomer thereof: wherein: X 1 is NH; X 2 is NH; X 3 is NH; X 4 is O; R 1 is selected from the group consisting of a side chain of persaphanine and structural and optical isomers thereof, wherein persephanine has the structure: R 2 is selected from the group consisting of hydrogen (H), deuterium (D), methyl, ethyl, linear or branched C 3 -C 20 alkyl, a side chain of amino acid, a linear or branched C 3 -C 20 alkenyl, and a linear or branched C 2 -C 20 alkynyl; R 3 is selected from the group consisting of alkyl or branched C 1 -C 6 alkyl, C 1 -C 6 alkyl ether, and C 1 -C 6 alkyl amine; R 4 , R 5 , R 6 , R 8 , R 9 are independently selected from the group consisting of straight chain or branched C 1 -C 5 alkyl, straight chain or branched C 1 -C 5 alkenyl, straight chain or branched C 1 -C 5 alkynyl, straight chain or branched C 1 -C 5 alkyl halide, straight chain or branched C 1 -C 5 alkenyl halide, straight chain or branched C 1 -C 5 alkynyl halide, straight chain or branched C 1 -C 5 alkyl amine, straight chain or branched C 1 -C 5 alkenyl amine, straight chain or branched C 1 -C 5 alkynyl amine, straight chain or branched C 1 -C 5 alkyl alcohol, straight chain or branched C 1 -C 5 alkenyl alcohol, straight chain or branched C 1 -C 5 alkynyl alcohol, straight chain or branched C 1 -C 5 alkyl ether, straight chain or branched C 1 -C 5 alkenyl ether, straight chain or branched C 1 -C 5 alkynyl ether, straight chain or branched C 1 -C 5 alkyl thiol, straight chain or branched C 1 -C 5 alkenyl thiol, straight chain or branched C 1 -C 5 alkynyl thiol, straight chain or branched C 1 -C 5 alkyl sulfide, straight chain or branched C 1 -C 5 alkenyl sulfide, straight chain or branched C 1 -C 5 alkynyl sulfide, straight chain or branched C 1 -C 5 alkyl sulfoxide, straight chain or branched C 1 -C 5 alkenyl sulfoxide, straight chain or branched C 1 -C 5 alkynyl sulfoxide, straight chain or branched C 1 -C 5 alkyl sulfone, straight chain or branched C 1 -C 5 alkenyl sulfone, straight chain or branched C 1 -C 5 alkynyl sulfone, straight chain or branched C 1 -C 5 alkyl nitrile, straight chain or branched C 1 -C 5 alkenyl nitrile, straight chain or branched C 1 -C 5 alkynyl nitrile, straight chain or branched C 1 -C 5 alkyl isonitrile, straight chain or branched C 1 -C 5 alkenyl isonitrile, straight chain or branched C 1 -C 5 alkynyl isonitrile, straight chain or branched C 1 -C 5 alkyl nitrite, straight chain or branched C 1 -C 5 alkenyl nitrite, straight chain or branched C 1 -C 5 alkynyl nitrite, straight chain or branched C 1 -C 5 alkyl oxime, straight chain or branched C 1 -C 5 alkenyl oxime, straight chain or branched C 1 -C 5 alkynyl oxime, straight chain or branched C 1 -C 5 alkyl nitroso, straight chain or branched C 1 -C 5 alkenyl nitroso, straight chain or branched C 1 -C 5 alkynyl nitroso, straight chain or branched C 1 -C 5 alkyl nitro, straight chain or branched C 1 -C 5 alkenyl nitro, straight chain or branched C 1 -C 5 alkynyl nitro, straight chain or branched C 1 -C 5 alkyl nitrate, straight chain or branched C 1 -C 5 alkenyl nitrate, straight chain or branched C 1 -C 5 alkynyl nitrate, straight chain or branched C 1 -C 5 alkyl imide, straight chain or branched C 1 -C 5 alkenyl imide, straight chain or branched C 1 -C 5 alkynyl imide, straight chain or branched C 1 -C 5 alkyl imine, straight chain or branched C 1 -C 5 alkenyl imine, straight chain or branched C 1 -C 5 alkynyl imine, straight chain or branched C 1 -C 5 alkyl amide, straight chain or branched C 1 -C 5 alkenyl amide, straight chain or branched C 1 -C 5 alkynyl amide, straight chain or branched C 1 -C 5 alkyl ester, straight chain or branched C 1 -C 5 alkenyl ester, straight chain or branched C 1 -C 5 alkynyl ester, straight chain or branched C 1 -C 5 alkyl ketone, straight chain or branched C 1 -C 5 alkenyl ketone, straight chain or branched C 1 -C 5 alkynyl ketone, straight chain or branched C 1 -C 5 alkyl carbonate, straight chain or branched C 1 -C 5 alkenyl carbonate, straight chain or branched C 1 -C 5 alkynyl carbonate, straight chain or branched C 1 -C 5 (cyclopropyl)alkyl, straight chain or branched C 1 -C 5 (cyclopropyl)alkenyl, straight chain or branched C 1 -C 5 (cyclopropyl)alkynyl, straight chain or branched C 1 -C 5 (cyclobutyl)alkyl, straight chain or branched C 1 -C 5 (cyclobutyl)alkenyl, straight chain or branched C 1 -C 5 (cyclobutyl)alkynyl, straight chain or branched C 1 -C 5 alkyl silane, straight chain or branched C 1 -C 5 alkenyl silane, straight chain or branched C 1 -C 5 alkynyl silane, straight chain or branched C 1 -C 5 alkyl, straight chain or branched C 1 -C 5 alkynyl, methyl, ethyl, propyl, butyl, methyl imidazole, butyl amine, propyl guanidine, methyl-1-ol, ethyl-2-ol, ethyl-1-ol, ethyloic acid, propanoic acid, carboxymethyl, carboxyethyl, ethylamide, propylamide, methyl-1-thiol, ethyl-1-thiol, methyl sulfane, ethyl sulfane, isobutyl, sec-butyl, Cert-butyl, and isopropyl; R 7 is selected from the group consisting of straight chain or branched C 1 -C 5 alkyl alcohol, straight chain or branched C 1 -C 5 alkenyl alcohol, straight chain or branched C 1 -C 5 alkynyl alcohol, straight chain or branched C 1 -C 5 alkyl amine, straight chain or branched C 1 -C 5 alkenyl amine, straight chain or branched C 1 -C 5 alkynyl amine, straight chain or branched C 1 -C 5 alkyl thiol, straight chain or branched C 1 -C 5 alkenyl thiol, and straight chain or branched C 1 -C 5 alkynyl thiol; and R 10 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 , R 17 and R 18 are independently selected from the group consisting of H, D, linear or branched C 1 -C 5 alkyl, methyl, and ethyl. 2. The method of claim 1 , wherein the fungal infection is an ocular fungal infection and the compound is topically administered. 3. The method of claim 1 , wherein the compound comprising Formula II is:

Assignees

Inventors

Classifications

  • Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00) · CPC title

  • C07K11/02Primary

    cyclic, e.g. valinomycins {; Derivatives thereof} · CPC title

  • A61K45/06Primary

    Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca · CPC title

  • Antimycotics · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11643438B2 cover?
Cyclic depsipeptide-class molecules, referred to herein as persephacins (including analogs thereof), having similarities to aureobasidin A, are described. The persephacins have antimicrobial activity, such as antifungal activity against a diverse range of clinically-relevant fungal pathogens, antiprotozoan parasite activity, and antibacterial activity, and can be used for example in treatments …
Who is the assignee on this patent?
Univ Oklahoma
What technology area does this patent fall under?
Primary CPC classification C07K11/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).